1. Detailed anaphylaxis ADR reports important

   News item 24 June 2023 Pages: 1 - 1

2. Harvard Drug Group label mix-up: dronabinol and ziprasidone capsules recalled

   News item 24 June 2023 Pages: 2 - 2

3. Hydroxychloroquine: risk of liver injury

   Media release 24 June 2023 Pages: 3 - 3

4. Kamini tablets pose serious health risk

   News item 24 June 2023 Pages: 4 - 4

5. Levothyroxine-related vertigo

   News item 24 June 2023 Pages: 5 - 5

6. No adverse outcomes after methotrexate use by men preconception

   News item 24 June 2023 Pages: 6 - 6

7. PI updates for ceftriaxone, flucloxacillin, teicoplanin, tofacitinib

   News item 24 June 2023 Pages: 7 - 7

8. Tramadol warnings and precautions updated

   News item 24 June 2023 Pages: 8 - 8

9. Transverse myelitis after COVID-19 vaccination

   News item 24 June 2023 Pages: 9 - 9

10. Apixaban is safest DOAC in terms of non-major bleeding

    Clinical study 24 June 2023 Pages: 10 - 10

11. OTC opioid-related ventricular arrhythmias and deaths

    Clinical study 24 June 2023 Pages: 11 - 11

12. Upadacitinib increases risk of herpes zoster and NMSC

    Clinical study 24 June 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 24 June 2023 Pages: 13 - 13

14. Abciximab

    Case report 24 June 2023 Pages: 14 - 14

15. Acenocoumarol/aspirin

    Case report 24 June 2023 Pages: 15 - 15

16. Acetic-acid/alginic-acid

    Case report 24 June 2023 Pages: 16 - 16

17. Adalimumab/certolizumab-pegol

    Case report 24 June 2023 Pages: 17 - 17

18. Afatinib/cisplatin/gemcitabine

    Case report 24 June 2023 Pages: 18 - 18

19. Albendazole

    Case report 24 June 2023 Pages: 19 - 19

20. Alendronic-acid

    Case report 24 June 2023 Pages: 20 - 20

21. Allopurinol/azacitidine

    Case report 24 June 2023 Pages: 21 - 21

22. Amantadine/lorazepam

    Case report 24 June 2023 Pages: 22 - 22

23. Aminolevulinic-acid

    Case report 24 June 2023 Pages: 23 - 23

24. Amiodarone

    Case report 24 June 2023 Pages: 24 - 24

25. Amiodarone/baricitinib/favipiravir

    Case report 24 June 2023 Pages: 25 - 25

26. Amoxicillin/clarithromycin/esomeprazole

    Case report 24 June 2023 Pages: 26 - 26

27. Amoxicillin/clarithromycin/lansaprazole

    Case report 24 June 2023 Pages: 27 - 27

28. Amoxicillin/clarithromycin/omeprazole

    Case report 24 June 2023 Pages: 28 - 28

29. Amoxicillin/clavulanic-acid

    Case report 24 June 2023 Pages: 29 - 29

30. Amphotericin B/potassium chloride/sulfadiazine

    Case report 24 June 2023 Pages: 30 - 30

31. Anakinra/hydroxychloroquine

    Case report 24 June 2023 Pages: 31 - 31

32. Antiarrhythmics

    Case report 24 June 2023 Pages: 32 - 32

33. Antibacterials

    Case report 24 June 2023 Pages: 33 - 33

34. Antibacterials

    Case report 24 June 2023 Pages: 34 - 34

35. Antibacterials

    Case report 24 June 2023 Pages: 35 - 36

36. Antibacterials

    Case report 24 June 2023 Pages: 36 - 36

37. Antibacterials/dexamethasone/remdesivir

    Case report 24 June 2023 Pages: 37 - 37

38. Antibacterials/tacrolimus

    Case report 24 June 2023 Pages: 38 - 38

39. Antidepressants

    Case report 24 June 2023 Pages: 39 - 39

40. Antifungals

    Case report 24 June 2023 Pages: 40 - 40

41. Antifungals/antineoplastics

    Case report 24 June 2023 Pages: 41 - 41

42. Antineoplastic drugs

    Case report 24 June 2023 Pages: 42 - 42

43. Antineoplastics

    Case report 24 June 2023 Pages: 43 - 43

44. Antineoplastics

    Case report 24 June 2023 Pages: 44 - 44

45. Antineoplastics

    Case report 24 June 2023 Pages: 45 - 45

46. Antineoplastics

    Case report 24 June 2023 Pages: 46 - 46

47. Antineoplastics

    Case report 24 June 2023 Pages: 47 - 47

48. Antineoplastics

    Case report 24 June 2023 Pages: 48 - 48

49. Antineoplastics

    Case report 24 June 2023 Pages: 49 - 49

50. Antineoplastics

    Case report 24 June 2023 Pages: 50 - 50